Invesco
ABEO icon

Invesco’s Abeona Therapeutics ABEO Stock Holding History

Invesco’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
23,724
+745
+3% +$4.09K ﹤0.01% 3669
2026
Q1 		$103K Sell
22,979
-81
-0.4% -$405 ﹤0.01% 3621
2025
Q4 		$122K Buy
23,060
+49
+0.2% +$247 ﹤0.01% 3617
2025
Q3 		$121K Buy
23,011
+96
+0.4% +$609 ﹤0.01% 3659
2025
Q2 		$130K Buy
+22,915
New +$130K ﹤0.01% 3612
2021
Q2 		– Sell
-453
Closed -$21K – 3957
2021
Q1 		$21K Buy
+453
New +$25K ﹤0.01% 3847
2020
Q2 		– Sell
-2,405
Closed -$126K – 3635
2020
Q1 		$126K Buy
+2,405
New +$161K ﹤0.01% 3516
2018
Q4 		– Sell
-4,881
Closed -$1.56M – 3812
2018
Q3 		$1.56M Sell
4,881
-217
-4% -$77K ﹤0.01% 2922
2018
Q2 		$2.04M Buy
+5,098
New +$2.23M ﹤0.01% 2744
2018
Q1 		– Sell
-8,619
Closed -$3.42M – 3707
2017
Q4 		$3.42M Buy
+8,619
New +$3.56M ﹤0.01% 2216
2017
Q3 		– Sell
-459
Closed -$73K – 3645
2017
Q2 		$73K Sell
459
-38
-8% -$5.18K ﹤0.01% 3657
2017
Q1 		$62K Buy
+497
New +$64.1K ﹤0.01% 3673
2015
Q3 		– Sell
-32
Closed -$4K – 3779
2015
Q2 		$4K Buy
+32
New +$4.81K ﹤0.01% 4275

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco's ABEO Position: Q2 2026 in Review

Invesco increased its Abeona Therapeutics (ABEO) stake by 3.2% in Q2 2026, buying an estimated $4.09K and bringing the position to 23,724 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #3669.

Invesco first reported a position in ABEO in Q2 2015 and has held it in 13 quarters since. The position peaked at $3.42M in Q4 2017. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Invesco held 23,724 shares of Abeona Therapeutics worth $147K as of Q2 2026.
  • Invesco bought 745 Abeona Therapeutics shares in Q2 2026, an estimated $4.09K.
  • Abeona Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3669 holding.
  • Invesco first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 13 quarters since.
  • Invesco's Abeona Therapeutics position peaked at $3.42M in Q4 2017.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.